Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Rhythm Pharmaceuticals (RYTM) Income from Continuing Operations (2016 - 2025)

Rhythm Pharmaceuticals (RYTM) has disclosed Income from Continuing Operations for 10 consecutive years, with 47533000.0 as the latest value for Q4 2025.

  • Quarterly Income from Continuing Operations fell 9.71% to 47533000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 196567000.0 through Dec 2025, up 24.57% year-over-year, with the annual reading at 196539000.0 for FY2025, 24.58% up from the prior year.
  • Income from Continuing Operations for Q4 2025 was 47533000.0 at Rhythm Pharmaceuticals, up from 52904000.0 in the prior quarter.
  • The five-year high for Income from Continuing Operations was 43750000.0 in Q1 2021, with the low at 141372000.0 in Q1 2024.
  • Average Income from Continuing Operations over 5 years is 45010050.0, with a median of 44515500.0 recorded in 2022.
  • The sharpest move saw Income from Continuing Operations skyrocketed 228.06% in 2021, then crashed 220.07% in 2022.
  • Over 5 years, Income from Continuing Operations stood at 50855000.0 in 2021, then rose by 16.44% to 42493000.0 in 2022, then grew by 2.02% to 41633000.0 in 2023, then decreased by 4.07% to 43328000.0 in 2024, then fell by 9.71% to 47533000.0 in 2025.
  • According to Business Quant data, Income from Continuing Operations over the past three periods came in at 47533000.0, 52904000.0, and 46632000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.